These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 16224247)

  • 1. Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis.
    Tidball JG; Wehling-Henricks M
    Curr Opin Rheumatol; 2005 Nov; 17(6):707-13. PubMed ID: 16224247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired necrotizing myopathies.
    Allenbach Y; Benveniste O
    Curr Opin Neurol; 2013 Oct; 26(5):554-60. PubMed ID: 23995277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies.
    Farini A; Villa C; Tripodi L; Legato M; Torrente Y
    Front Immunol; 2021; 12():666879. PubMed ID: 34335568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies.
    Emslie-Smith AM; Arahata K; Engel AG
    Hum Pathol; 1989 Mar; 20(3):224-31. PubMed ID: 2470663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies.
    Becker N; Moore SA; Jones KA
    Acta Neuropathol Commun; 2022 Feb; 10(1):17. PubMed ID: 35135626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major histocompatibility complex and inflammatory cell subtype expression in inflammatory myopathies and muscular dystrophies.
    Nagappa M; Nalini A; Narayanappa G
    Neurol India; 2013; 61(6):614-21. PubMed ID: 24441329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders.
    Appleyard ST; Dunn MJ; Dubowitz V; Rose ML
    Lancet; 1985 Feb; 1(8425):361-3. PubMed ID: 2857418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which nonautoimmune myopathies are most frequently misdiagnosed as myositis?
    Mammen AL
    Curr Opin Rheumatol; 2017 Nov; 29(6):618-622. PubMed ID: 28832350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy.
    Artlett CM; Sassi-Gaha S; Ramos RC; Miller FW; Rider LG
    Arthritis Res Ther; 2015 Sep; 17(1):238. PubMed ID: 26338728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Standard treatment for myositis and muscular dystrophies].
    Schmidt J; Vorgerd M
    Nervenarzt; 2011 Jun; 82(6):723-32. PubMed ID: 21614632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of major histocompatibility complex class I molecules in autoimmune myositis.
    Nagaraju K
    Curr Opin Rheumatol; 2005 Nov; 17(6):725-30. PubMed ID: 16224250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine expression profile in idiopathic inflammatory myopathies.
    Tews DS; Goebel HH
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):342-7. PubMed ID: 8786392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies.
    Engel AG; Arahata K
    Hum Pathol; 1986 Jul; 17(7):704-21. PubMed ID: 3459704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies.
    Wiendl H; Mitsdoerffer M; Schneider D; Melms A; Lochmuller H; Hohlfeld R; Weller M
    Brain; 2003 May; 126(Pt 5):1026-35. PubMed ID: 12690043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].
    Váncsa A; Dankó K
    Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathogenesis of inflammatory myopathies.
    Dalakas MC
    Ann Neurol; 1995 May; 37 Suppl 1():S74-86. PubMed ID: 8968219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies.
    Spuler S; Engel AG
    Neurology; 1998 Jan; 50(1):41-6. PubMed ID: 9443455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines and dendritic cells in inflammatory myopathies.
    Tournadre A; Miossec P
    Ann Rheum Dis; 2009 Mar; 68(3):300-4. PubMed ID: 19213746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired necrotizing myopathies].
    Allenbach Y; Benveniste O
    Rev Med Interne; 2013 Jun; 34(6):363-8. PubMed ID: 22998975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.